NCT04847453 2026-04-13Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain AmyloidosisNational Cancer Institute (NCI)Phase 1 Recruiting24 enrolled
NCT05898646 2026-03-30Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA TrialMayo ClinicPhase 2 Recruiting96 enrolled